'Carboplatin' presentation slideshows

ASCO 2006 Update: Gynecologic Cancers

604 views • 40 slides

Eric Pujade-Lauraine on behalf of all GCIG collaborators

CALYPSO trial. Carboplatin & Pegylated Liposomal Doxorubicin (PLD) versus Carboplatin & Paclitaxel in Relapsed, Platinum-sensitive Ovarian Cancer. Eric Pujade-Lauraine on behalf of all GCIG collaborators. Background.

472 views • 27 slides

Background

Whitney Jones, PharmD Candidate 1 ; LeAnn B. Norris, PharmD, BCPS 2 ; P. Brandon Bookstaver, PharmD, BCPS 2 ; Richard Schulz, PhD 2 1 University of South Carolina College of Pharmacy, Columbia, SC; 2 South Carolina College of Pharmacy, USC Campus, Columbia, SC.

332 views • 12 slides

Background

Whitney Jones, PharmD Candidate 1 ; LeAnn B. Norris, PharmD, BCPS 2 ; P. Brandon Bookstaver, PharmD, BCPS 2 ; Richard Schulz, PhD 2 1 University of South Carolina College of Pharmacy, Columbia, SC; 2 South Carolina College of Pharmacy, USC Campus, Columbia, SC.

123 views • 12 slides

Authors: De Santis M et al, ASCO 2010 Abstract: LBA4519 Reviewed by: Dr. Lori Wood

Randomized phase II/III trial comparing gemcitabine/ carboplatin (GC) and methotrexate/carboplatin/ vinblastine (M-CAVI) in patients (pts) with advanced urothelial cancer (UC) unfit for cisplatin-based chemotherapy (CHT): Phase III results of EORTC study 30986.

218 views • 8 slides

Pujade-Lauraine E et al. ASCO 2009; Abstract LBA5509. (Oral Presentation)

CALYPSO Trial: Carboplatin & Pegylated Liposomal Doxorubicin (PLD) versus Carboplatin & Paclitaxel in Relapsed, Platinum-Sensitive Ovarian Cancer. Pujade-Lauraine E et al. ASCO 2009; Abstract LBA5509. (Oral Presentation). Introduction.

88 views • 8 slides

Carboplatin Injection

Labdhi commenced operations in 1984 as a bulk drug manufacturer and, is, today diversified and grown as a leading manufacturing & marketing Life Science organisation. Labdhi is one of the experienced players in the pharmaceutical formulation and therapeutic segments.We cater to most categories with unique health solutions and many new product categories are being evolved.

108 views • 6 slides

??Carboplatin??????????

??Carboplatin??????????.

91 views • 2 slides

Supple 3A. Toxicity associated with carboplatin and paclitaxel

Supple 3A. Toxicity associated with carboplatin and paclitaxel.

147 views • 1 slides

75 views • 1 slides

176 views • 1 slides

Supple 3B. Toxicity associated with carboplatin and paclitaxel

Supple 3B. Toxicity associated with carboplatin and paclitaxel.

106 views • 1 slides